Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab

Ondřej Fiala, Katarína Rejleková, Tomas Buchler, Hana Študentová, Alexandr Poprach, Michal Vočka, Petr Hošek, Jindřich Kopecký, Martin Matějů, Anežka Zemánková, Martina Spisarová, Michaela Tkadlecová, Peter Priester, Jan Kouřil, Radka Lohynská, Lucie Grmelová, Alexander Savka, Katarína Štefániková, Jana Obertová, Dominika Šiková, Petr Stránský, Bohuslav Melichar, Patrik Palacka

Open source

DOI
10.1038/s41598-025-32593-8
Published
2025-12-21
Container
Scientific Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-32593-8,
  title = {Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab},
  author = {Ondřej Fiala and Katarína Rejleková and Tomas Buchler and Hana Študentová and Alexandr Poprach and Michal Vočka and Petr Hošek and Jindřich Kopecký and Martin Matějů and Anežka Zemánková and Martina Spisarová and Michaela Tkadlecová and Peter Priester and Jan Kouřil and Radka Lohynská and Lucie Grmelová and Alexander Savka and Katarína Štefániková and Jana Obertová and Dominika Šiková and Petr Stránský and Bohuslav Melichar and Patrik Palacka},
  year = {2025},
  journal = {Scientific Reports},
  doi = {10.1038/s41598-025-32593-8},
  url = {https://doi.org/10.1038/s41598-025-32593-8}
}

RIS

TY  - JOUR
TI  - Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab
AU  - Ondřej Fiala
AU  - Katarína Rejleková
AU  - Tomas Buchler
AU  - Hana Študentová
AU  - Alexandr Poprach
AU  - Michal Vočka
AU  - Petr Hošek
AU  - Jindřich Kopecký
AU  - Martin Matějů
AU  - Anežka Zemánková
AU  - Martina Spisarová
AU  - Michaela Tkadlecová
AU  - Peter Priester
AU  - Jan Kouřil
AU  - Radka Lohynská
AU  - Lucie Grmelová
AU  - Alexander Savka
AU  - Katarína Štefániková
AU  - Jana Obertová
AU  - Dominika Šiková
AU  - Petr Stránský
AU  - Bohuslav Melichar
AU  - Patrik Palacka
PY  - 2025
JO  - Scientific Reports
DO  - 10.1038/s41598-025-32593-8
UR  - https://doi.org/10.1038/s41598-025-32593-8
ER  - 

APA

Fiala, O., Rejleková, K., Buchler, T., Študentová, H., Poprach, A., Vočka, M., Hošek, P., Kopecký, J., Matějů, M., Zemánková, A., Spisarová, M., Tkadlecová, M., Priester, P., Kouřil, J., Lohynská, R., Grmelová, L., Savka, A., Štefániková, K., Obertová, J., Šiková, D., Stránský, P., Melichar, B., & Palacka, P. (2025). Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab. Scientific Reports. https://doi.org/10.1038/s41598-025-32593-8

Source records